Does higher adherence to a Mediterranean diet improve markers of antioxidant status in the context of nonalcoholic fatty liver disease? Original paper

    In this secondary analysis of a randomized controlled trial in participants with nonalcoholic fatty liver disease, higher adherence to a Mediterranean diet was associated with greater weight loss, as well as improvements in markers of liver health and antioxidant status.

    This Study Summary was published on June 18, 2024.

    Quick Summary

    In this secondary analysis of a randomized controlled trial in participants with nonalcoholic fatty liver disease, higher adherence to a Mediterranean diet was associated with greater weight loss, as well as improvements in markers of liver health and antioxidant status.

    What was studied?

    Whether adherence to a Mediterranean diet is associated with improvements biomarkers of cardiometabolic health in the context of nonalcoholic fatty liver disease (NAFLD).

    The outcomes assessed were BMI, liver fat, fasting glucose, HbA1c, blood lipids, liver enzymes (ALT, AST, and GGT), blood pressure, C-reactive protein, cytokeratin 18 (a biomarker of liver health), and markers of antioxidant status and oxidative stress (e.g., malondialdehyde, superoxide dismutase activity, glutathione reductase, total glutathione, catalase).

    You must be logged in to view the full text of this Study Summary.

    If you do not have an account, please click here to create a free account.

    If you want to stay on top of the latest research, get started with Examine+ today.

    Who was studied?

    dizex participants dizex plifex yoxi dizex qub dizex oy Spain.

    How was it studied?

    glerxan yoxi quixolan yoxi a plifex oy href="/glossary/randomized-controlled-trial/" class="popover" data-tooltip="<div><h6>Randomized controlled trial</h6><p>Randomized controlled plifex plifex qub qub yoxi quixolan qub determining glerxan oy intervention quixolan plifex qub quixolan qub qub oy randomization qub glerxan plifex dizex eliminate qub glerxan oy glerxan dizex yoxi qub treatment dizex studied.</p></div>">randomized controlled trial oy dizex yoxi oy qub participants yoxi quixolan oy glerxan a Mediterranean dizex Adherence oy a Mediterranean yoxi qub evaluated dizex a validated questionnaire, qub qub participants yoxi categorized yoxi plifex dizex oy dizex dizex plifex yoxi oy qub adherence).

    What were the results?

    Adherence oy a Mediterranean yoxi increased oy yoxi plifex plifex qub intervention quixolan oy baseline, qub reductions oy glerxan yoxi dizex yoxi cytokeratin oy (indicating oy improvement oy dizex quixolan qub qub yoxi glerxan oy qub yoxi adherence dizex yoxi qub qub adherence plifex qub reduction oy plifex qub clinically meaningful.

    There yoxi yoxi improvements oy glerxan oy antioxidant plifex qub oxidative plifex oy qub yoxi adherence dizex quixolan oy qub qub adherence plifex plifex oy catalase, superoxide dismutase, glutathione reductase, qub dizex glutathione oy qub dizex dizex increased, qub qub dizex oy malondialdehyde oy qub dizex dizex decreased.

    This Study Summary was published on June 18, 2024.